midazolam + fentanyl + rocuronium

This is a combination of three pharmaceutical agents—midazolam, fentanyl, and rocuronium—commonly used for the induction of anesthesia, particularly in rapid sequence intubation (RSI) and emergency airway management. - **Midazolam** is a short-acting benzodiazepine that acts as a central nervous system depressant by enhancing the effect of gamma-aminobutyric acid (GABA) at the GABA(A) receptor, producing sedation, anxiolysis, amnesia, and muscle relaxation. - **Fentanyl** is a potent synthetic opioid analgesic that primarily acts as an agonist at the mu-opioid receptor to provide analgesia and additional sedation. - **Rocuronium** is a non-depolarizing neuromuscular blocking agent that competitively inhibits acetylcholine at nicotinic receptors on skeletal muscle endplates, resulting in paralysis to facilitate intubation or surgery. This combination regimen provides rapid onset of unconsciousness (midazolam), profound analgesia (fentanyl), and muscular relaxation/paralysis (rocuronium), making it suitable for procedures requiring secure airway control such as after cardiac arrest or in trauma settings[1][2][3]. The combination has been shown to be effective for prehospital or emergency department anesthesia but may cause reductions in systolic blood pressure post-induction[2].